Orion board member Ari Lehtoranta receives share-based incentive

Orion Oyj has disclosed that board member Ari Lehtoranta acquired 568 shares of the company on May 3, 2019. The acquisition was part of the company's share-based incentive scheme.

The transaction took place off-exchange and was executed at a price of zero euros, as is standard for the payout of incentive remuneration. The disclosure follows EU Market Abuse Regulation requirements, which mandate that listed companies report transactions made by persons discharging managerial responsibilities.

This transaction reflects the standard execution of Orion’s compensation policies for its leadership team and does not materially alter the shareholding structure of the pharmaceutical company.